Literature DB >> 20716070

Intravenous vs intramuscular ketamine for pediatric procedural sedation by emergency medicine specialists: a review.

Conor Deasy1, Franz E Babl.   

Abstract

Ketamine is a general anesthetic agent widely used for pediatric procedural sedation outside the operating theater by nonanesthesiologists. In a setting where efficacy and safety of the agent are paramount, there are conflicting recommendations in terms of optimal mode of parenteral administration, as well as optimal dosage and need for the coadministration of adjunctive agents to decrease side effects. We investigated existing evidence to determine whether ketamine should be best administered intravenously or intramuscularly. This analysis was made difficult by limited direct comparisons of both modes of parenteral administration and a lack of consistent definitions for key outcomes such as 'effectiveness,''adverse events,''hypoxia,''ease of completion of the procedure,' and 'satisfaction' across studies that have evaluated ketamine. Based on large data sets, the safety and efficacy of both modes of administration are broadly similar. Although data on head to head comparisons of intravenous and intramuscular ketamine is limited, based on our analysis, we conclude that the trends indicate ketamine is ideally administered intravenously.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20716070     DOI: 10.1111/j.1460-9592.2010.03338.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  8 in total

1.  Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells.

Authors:  William Slikker; Fang Liu; Shuo W Rainosek; Tucker A Patterson; Natalya Sadovova; Joseph P Hanig; Merle G Paule; Cheng Wang
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

2.  Behavioral effects of prenatal ketamine exposure in rhesus macaques are dependent on MAOA genotype.

Authors:  John P Capitanio; Laura A Del Rosso; Laura A Calonder; Shelley A Blozis; M Cecilia T Penedo
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-16       Impact factor: 3.157

3.  Upregulation of miR-137 protects anesthesia-induced hippocampal neurodegeneration.

Authors:  Changshun Huang; Xingcai Zhang; Jungang Zheng; Chunru Chen; Yijun Chen; Juan Yi
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.

Authors:  Christoph P Hornik; Daniel Gonzalez; John van den Anker; Andrew M Atz; Ram Yogev; Brenda B Poindexter; Kee Chong Ng; Paula Delmore; Barrie L Harper; Chiara Melloni; Andrew Lewandowski; Casey Gelber; Michael Cohen-Wolkowiez; Jan Hau Lee
Journal:  J Clin Pharmacol       Date:  2018-04-20       Impact factor: 2.860

Review 5.  What Works and What's Safe in Pediatric Emergency Procedural Sedation: An Overview of Reviews.

Authors:  Lisa Hartling; Andrea Milne; Michelle Foisy; Eddy S Lang; Douglas Sinclair; Terry P Klassen; Lisa Evered
Journal:  Acad Emerg Med       Date:  2016-04-24       Impact factor: 3.451

6.  Ketamine Sedation in Gastrointestinal Endoscopy in Children.

Authors:  Ayman E Eskander; Nevine R El Baroudy; Amira S El Refay
Journal:  Open Access Maced J Med Sci       Date:  2016-07-26

7.  A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia.

Authors:  Mohammad Gharavifard; Behnaz Boroumand Reza Zadeh; Hamid Zamani Moghadam
Journal:  Emerg (Tehran)       Date:  2015

8.  Onset and Effect Duration of Intrabuccal Space and Intramuscular Ketamine in Pediatrics.

Authors:  Saeed Majidi; Abdolrahman Parna; Majid Zamani; Kourosh Akhbari
Journal:  Adv Biomed Res       Date:  2018-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.